You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for GNP ALL DAY ALLERGY


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP ALL DAY ALLERGY

Average Pharmacy Cost for GNP ALL DAY ALLERGY

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP ALL DAY ALLERGY 10 MG SFGL 46122-0613-63 0.19143 EACH 2024-12-18
GNP ALL DAY ALLERGY 10 MG SFGL 46122-0613-63 0.19118 EACH 2024-11-20
GNP ALL DAY ALLERGY 10 MG SFGL 46122-0613-63 0.18832 EACH 2024-10-23
GNP ALL DAY ALLERGY 10 MG SFGL 46122-0613-63 0.18780 EACH 2024-09-18
GNP ALL DAY ALLERGY 10 MG SFGL 46122-0613-63 0.18280 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Allergy Treatments: A Focus on GNP ALL DAY ALLERGY

Introduction to the Allergy Treatment Market

The global allergy treatment market is experiencing significant growth, driven by increasing prevalence of allergic conditions, advancements in diagnostic and therapeutic technologies, and changing lifestyles. Here, we will delve into the market analysis and price projections, with a specific focus on products like GNP ALL DAY ALLERGY.

Market Size and Growth Projections

The global allergy diagnostics and therapeutics market was estimated at USD 33.06 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030[1].

Similarly, the allergy treatment market is expected to reach USD 21.05 billion in 2024 and grow at a CAGR of 8.10% to reach USD 31.07 billion by 2029[4].

Key Drivers of Market Growth

Several factors are driving the growth of the allergy treatment market:

  • Increasing Prevalence of Allergies: The rising number of cases of allergic patients, particularly among children and the geriatric population, is a significant driver. For instance, seasonal allergic rhinitis affects approximately 26% of adults and 19% of children in the United States[1][4].
  • Advancements in Diagnostic and Therapeutic Technologies: Improvements in in vitro diagnostic (IVD) techniques and the introduction of advanced drugs like immunotherapy are boosting market growth[1].
  • Changing Lifestyles and Environmental Factors: Growing pollution, unhealthy habits, and urbanization contribute to the increasing incidence of allergic conditions[1][3].

Segmentation of the Market

The allergy treatment market is segmented into therapeutics and diagnostics.

  • Therapeutics Segment: This segment held the largest revenue share, with over 81.67% in 2023, due to its focus on treating allergic conditions. Epinephrine, used for severe allergic reactions like anaphylaxis, dominates this segment[1].
  • Diagnostics Segment: Expected to witness the fastest CAGR over the forecast period, diagnostics are crucial for early identification and targeted therapeutic interventions. The consumables segment, including allergen microarray kits, is anticipated to grow significantly[1].

Regional Market Analysis

  • North America: This region is expected to hold a significant share of the allergy treatment market due to the high prevalence of allergies and increased research activities[4].
  • Asia Pacific: This region is estimated to grow at the highest CAGR over the forecast period, driven by improving access to diagnostic tools and increasing adoption of IVD techniques[1][4].

GNP ALL DAY ALLERGY: Product Overview

GNP ALL DAY ALLERGY, typically containing cetirizine, is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching.

  • Common Brand Name: Cetirizine is commonly known by the brand name Zyrtec[2][5].
  • Usage and Side Effects: It is prescribed to alleviate symptoms of allergies but can cause side effects like drowsiness, tiredness, dry mouth, and stomach pain, especially in children[2][5].

Price Projections and Market Dynamics

The pricing of allergy medications like GNP ALL DAY ALLERGY can be influenced by several factors:

  • Market Competition: The presence of multiple brands and generic versions can impact pricing. For example, GNP ALL DAY ALLERGY is available at around $29.99 for a 90-tablet pack[2][5].
  • Regulatory Environment: Changes in regulatory policies and healthcare reimbursement can affect the pricing and accessibility of these medications.
  • Technological Advancements: The introduction of new diagnostic tools and therapeutic options can shift market dynamics and influence pricing.

Given the growing demand for allergy treatments and the competitive landscape, prices for products like GNP ALL DAY ALLERGY are likely to remain stable or see moderate increases over the forecast period.

Key Takeaways

  • The global allergy treatment market is growing significantly due to increasing prevalence of allergies and advancements in diagnostics and therapeutics.
  • The therapeutics segment dominates the market, with epinephrine being a crucial component.
  • Diagnostics are expected to grow rapidly, driven by the need for early and precise identification of allergic conditions.
  • Regional growth is varied, with North America holding a significant share and Asia Pacific showing the highest growth rate.
  • Products like GNP ALL DAY ALLERGY, containing cetirizine, are widely used and priced competitively.

FAQs

What is the current size of the global allergy treatment market?

The global allergy treatment market was estimated at USD 33.06 billion in 2023[1].

What is the projected growth rate of the allergy treatment market?

The market is projected to grow at a CAGR of 8.7% from 2024 to 2030[1].

Which segment dominates the allergy treatment market?

The therapeutics segment holds the largest revenue share, with over 81.67% in 2023[1].

What are the common side effects of cetirizine?

Common side effects include drowsiness, tiredness, dry mouth, and stomach pain, especially in children[2][5].

Which region is expected to grow at the highest CAGR in the allergy treatment market?

The Asia Pacific region is estimated to grow at the highest CAGR over the forecast period[1][4].

Sources:

  1. Grand View Research: Allergy Diagnostics And Therapeutics Market Report, 2030
  2. Keaveny Drug: GNP ALLERGY 10MG CETIR TAB 90
  3. GlobeNewswire: Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034
  4. Mordor Intelligence: Allergy Treatment Market Analysis | Industry Forecast, Size & Report
  5. Davis Islands Pharmacy: GNP ALLERGY 10MG CETIR TAB 90

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.